Search

everythinglearnresearchcommunity

for

Search:↓

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

ESR2 gene linked to female-pattern hair loss.

Researchers created a model to understand heart aging, highlighting the role of microRNAs and identifying key genes and pathways involved.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Researchers created a model to understand heart aging, highlighting key genes and pathways, and suggesting miR-208a as a potential heart attack biomarker.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Plum-blossom needle therapy shows promise for treating hair loss but needs more research.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

GLP-1 agonists may help treat certain skin conditions.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Certain Prakruti types are more prone to early male pattern baldness.

Excess androgens may cause PCOS, not just be a symptom.

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Activating the Eda/Edar pathway improves wound healing by enhancing hair follicle growth.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.